Inventor · disambiguated record
Tadamitsu Kishimoto
Also filed as: KISHIMOTO TADAMITSU
41 granted patents·11 pending applications·1,823 citations·filing 1982–2023
98Inventor score
Files withKISHIMOTO TADAMITSU15CHUGAI PHARMACEUTICAL CO LTD7AJINOMOTO KK5ONO PHARMACEUTICAL CO4ITO HIROAKI2
Top patents by PatentIndex Score
52 records- 0197US7320792B2Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonistCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Granted Jan 22, 2008·147 cites·3 claims
- 0297US5670373AAntibody to human interleukin-6 receptorFiled 1994·Granted Sep 23, 1997·270 cites·13 claims
- 0396US6723319B1Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 1999·Granted Apr 20, 2004·240 cites·4 claims
- 0495US5888510AChronic rheumatoid arthritis therapy containing IL-6 antagonist as effective componentCHUGAI PHARMACEUTICAL CO LTD·Filed 1995·Granted Mar 30, 1999·285 cites·11 claims
- 0594US7824674B2Preventive or therapeutic agent for inflammatory bowel disease comprising IL-6 antagonist as an active ingredientCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Granted Nov 2, 2010·89 cites·4 claims
- 0693US5171840AReceptor protein for human B cell stimulatory factor-2KISHIMOTO TADAMITSU·Filed 1989·Granted Dec 15, 1992·49 cites·6 claims
- 0792US6410691B1Receptor protein for human B cell stimulatory factor-2Filed 1999·Granted Jun 25, 2002·82 cites·3 claims
- 0892US5480796AAntibodies against the receptor protein for human B cell stimulatory factor-2Filed 1992·Granted Jan 2, 1996·67 cites·3 claims
- 0991US8017121B2Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective componentCHUGAI SEIYAKU KABUSHIKA KAISHA·Filed 2001·Granted Sep 13, 2011·73 cites·3 claims
- 1090US8597644B2Method for treating psoriasis by administering an antibody to interleukin-6 receptorITO HIROAKI·Filed 2007·Granted Dec 3, 2013·16 cites·6 claims
- 1190US8562990B2Method of treating psoriatic arthritis with an IL-6 receptor antibodyITO HIROAKI·Filed 2011·Granted Oct 22, 2013·16 cites·16 claims
- 1288US6555555B1Fused thiophone derivatives and drugs containing the same as the active ingredientONO PHARMACEUTICAL CO·Filed 2002·Granted Apr 29, 2003·25 cites·4 claims
- 1386US5866689AMonoclonal antibodies to GP130 proteinTOSOH CORP·Filed 1997·Granted Feb 2, 1999·69 cites·17 claims
- 1485US8802092B2Mesothelioma therapeutic agentNISHIMOTO NORIHIRO·Filed 2008·Granted Aug 12, 2014·12 cites·27 claims
- 1585US5851793ARecombinant DNA encoding receptor protein for human B-cell stimulatory factor-2Filed 1995·Granted Dec 22, 1998·48 cites·42 claims
- 1684US5990282AReceptor protein for human B cell stimulatory factor-2Filed 1997·Granted Nov 23, 1999·45 cites·8 claims
- 1783US8617550B2Treatment of vasculitis with IL-6 antagonistNISHIMOTO NORIHIRO·Filed 2004·Granted Dec 31, 2013·17 cites·11 claims
- 1879US10550387B2Therapeutic agent for a lung disease and/or method for screening for the sameKISHIMOTO TADAMITSU·Filed 2016·Granted Feb 4, 2020·1 cites·9 claims
- 1978US6428979B1Receptor protein for human B cell stimulatory factor-2Filed 1999·Granted Aug 6, 2002·53 cites·40 claims
- 2078US6420391B1Fused thiophone derivatives and drugs containing the same as the active ingredientONO PHARMACEUTICAL CO·Filed 1999·Granted Jul 16, 2002·23 cites·12 claims
- 2177US5186931AComposition and method for supporting bone marrow transplantationAJINOMOTO KK·Filed 1989·Granted Feb 16, 1993·32 cites·2 claims
- 2276US2024294910A1Novel therapeutic agent for septicemia, and a method for screening for sameKISHIMOTO TADAMITSU·Filed 2023·Application pending·0 cites
- 2373US11279931B2Therapeutic agent for a lung disease and/or method for screening for the sameCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Mar 22, 2022·0 cites·15 claims
- 2465US8119126B2Inhibiting vascularization using antibodies to CXCR4 and SDF-1KISHIMOTO TADAMITSU·Filed 2004·Granted Feb 21, 2012·6 cites·6 claims
- 2565US5844082AHuman acute phase response factorKISHIMOTO TADAMITSU·Filed 1997·Granted Dec 1, 1998·25 cites·2 claims
- 2664US5132403AHuman gp130 proteinKISHIMOTO TADAMITSU·Filed 1990·Granted Jul 21, 1992·17 cites·3 claims
- 2763US7361737B2Mouse CXC chemokine receptorSHIONOGI & CO·Filed 2006·Granted Apr 22, 2008·0 cites·2 claims
- 2861US5126325AMethod for treating thrombocytopeniaAJINOMOTO KK·Filed 1990·Granted Jun 30, 1992·13 cites·8 claims
- 2961US4544632AHuman T cell lines and method of producing sameYAMAMURA YUICHI·Filed 1982·Granted Oct 1, 1985·15 cites·12 claims
- 3059US6514725B1STAT function-regulatory proteinKISHIMOTO TADAMITSU·Filed 1997·Granted Feb 4, 2003·11 cites·11 claims
- 3158US2025368724A1Novel therapeutic agent for inflammatory diseases and screening method thereofUNIV OSAKA·Filed 2023·Application pending·0 cites
- 3256US2008160553A1Method of preparing heart muscle cells and method of searching for remedy for heart diseasesTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 3354US5719042ANucleic acids encoding transcription factor APRF (acute phase response factor)KISHIMOTO TADAMITSU·Filed 1995·Granted Feb 17, 1998·16 cites·8 claims
- 3454US4675291AHuman cultured cell lineOTSUKA PHARMA CO LTD·Filed 1984·Granted Jun 23, 1987·12 cites·4 claims
- 3554US2018016576A1Novel Therapeutic Agent for Septicemia, and a Method for Screening for SameKISHIMOTO TADAMITSU·Filed 2015·Application pending·0 cites
- 3652US5215892AC/EBP2 gene and recombinant C/EBP2KISHIMOTO TADAMITSU·Filed 1990·Granted Jun 1, 1993·11 cites·11 claims
- 3752US2022193113A1Novel therapeutic agent for gastrointestinal cancer and method for screening for the sameUNIV OSAKA·Filed 2020·Application pending·0 cites
- 3851US2007134242A1Mesothelioma therapeutic agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Application pending·0 cites
- 3950US5362489AUse of recombinant B-cell differentiation factor for augmenting antibody production and stimulating bone marrow proliferationAJINOMOTO KK·Filed 1992·Granted Nov 8, 1994·8 cites·2 claims
- 4050US2004214896A1Hydroxamic acid derivatives, the methods for preparation thereof and pharmaceutical compositions comprising thereof, as an active ingredientONO PHARMACEUTICAL CO·Filed 2004·Application pending·0 cites
- 4149US2013236889A1Vascularization InhibitorsKISHIMOTO TADAMITSU·Filed 2011·Application pending·0 cites
- 4246US2007036785A1Pharmaceutical composition for treatment of diseases caused by IL-6 productionKISHIMOTO TADAMITSU·Filed 2006·Application pending·0 cites
- 4344US6770644B1Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredientONO PHARMACEUTICAL CO·Filed 2000·Granted Aug 3, 2004·0 cites·7 claims
- 4444US5470824AMethod to treat Kaposi's sarcomaUNIV CALIFORNIA·Filed 1991·Granted Nov 28, 1995·10 cites·1 claims
- 4543US5360894AC/EBP2 gene and recombinant C/EBP2KISHIMOTO TADAMITSU·Filed 1993·Granted Nov 1, 1994·6 cites·2 claims
- 4642US5541088ARecombinant process of producing non-glycosylated B-cell defferentiation factorAJINOMOTO KK·Filed 1994·Granted Jul 30, 1996·5 cites·1 claims
- 4742US5223611ADNA encoding for human GP130 proteinKISHIMOTO TADAMITSU·Filed 1992·Granted Jun 29, 1993·5 cites·5 claims
- 4842US2003175847A1Method of preparing heart muscle cells and method of searching for remedy for heart diseasesFiled 2001·Application pending·0 cites
- 4941US7247424B2Screening method for a substance having hypoglycemic activity by using STAT-induced inhibitor of STAT function-1KISHIMOTO TADAMITSU·Filed 2001·Granted Jul 24, 2007·0 cites·6 claims
- 5040US7074616B1Mouse CXC chemokine receptorSHIONOGI & CO·Filed 1997·Granted Jul 11, 2006·3 cites·11 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tadamitsu Kishimoto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →